# A Phase I Extension Trial of Repeated Infusions of ISF35

> **NCT00783588** · PHASE1 · COMPLETED · sponsor: **Memgen, LLC** · enrollment: 4 (actual)

## Conditions studied

- Chronic Lymphocytic Leukemia

## Interventions

- **BIOLOGICAL:** ISF35

## Key facts

- **NCT ID:** NCT00783588
- **Lead sponsor:** Memgen, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2008-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00783588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00783588, "A Phase I Extension Trial of Repeated Infusions of ISF35". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00783588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*